TENOXICAM TABLET

Šalis: Kanada

kalba: anglų

Šaltinis: Health Canada

Veiklioji medžiaga:

TENOXICAM

Prieinama:

AA PHARMA INC

ATC kodas:

M01AC02

INN (Tarptautinis Pavadinimas):

TENOXICAM

Dozė:

20MG

Vaisto forma:

TABLET

Sudėtis:

TENOXICAM 20MG

Vartojimo būdas:

ORAL

Vienetai pakuotėje:

250ML

Recepto tipas:

Prescription

Gydymo sritis:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Produkto santrauka:

Active ingredient group (AIG) number: 0122416001; AHFS:

Autorizacija statusas:

APPROVED

Leidimo data:

2022-09-01

Prekės savybės

_TENOXICAM (Tenoxicam Tablets) _
_Page 1 of 31_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
TENOXICAM
Tenoxicam Tablets
Tablets, 20 mg and Oral
House Standard
Anti-inflammatory, Analgesic Agent
AA PHARMA INC.
1165 Creditstone Road, Unit #1
Vaughan, Ontario
L4K 4N7
www.aapharma.ca
Submission Control Number: 266573
Date of
Initial
Authorization:
June
09, 2010
Date of Revision:
AUG
31, 2022
_ _
_TENOXICAM (Tenoxicam Tablets) _
_Page 2 of 31_
RECENT MAJOR LABEL CHANGES
2 Contraindications
3 Serious Warnings and Precautions Box
7 Warnings and Precautions
7 Warnings and Precautions, 7.1.1 Pregnant Women
08/2022
TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
RECENT MAJOR LABEL CHANGES
...........................................................................................
2
TABLE OF CONTENTS
.............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1
INDICATIONS
..............................................................................................................
4
1.1
Pediatrics
...................................................................................................................
4
1.2
Geriatrics
...................................................................................................................
4
2
CONTRAINDICATIONS
.................................................................................................
4
3
SERIOUS WARNINGS AND PRECAUTIONS BOX
............................................................ 5
4
DOSAGE AND ADMINISTRATION
.................................................................................
5
4.2
Recommended Dose and Dosage Adjustment
......................................................... 5
4.5
Missed Dose
.................................................................................................